Insider Transactions in Q2 2023 at Phase Bio Pharmaceuticals Inc (PHAS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2023
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+9.09%
|
-
|
|
May 19
2023
|
Caroline M Loewy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
-
|
|
May 19
2023
|
Alex Sapir Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
-
|
|
May 19
2023
|
Edmund Harrigan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+27.78%
|
-
|
|
May 19
2023
|
William D. Humphries Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,538
+50.0%
|
-
|
|
May 19
2023
|
Clay Thorp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+9.27%
|
-
|
|
May 19
2023
|
Richard Van Den Broek Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+100.0%
|
-
|